Gabapentin for Sleep: Off-Label Evidence and Risks
Last updated November 5, 2026
Key Takeaways
- Gabapentin is FDA-approved for nerve pain after shingles and for certain seizures, not for insomnia, so using it for sleep is off-label.
- In an industry-linked trial of 377 adults, single doses of 250 or 500 mg increased slow-wave sleep and total sleep time in a lab model of disrupted sleep.
- The strongest sleep-related evidence is for restless legs syndrome, where the American Academy of Sleep Medicine strongly recommends gabapentin.
- Gabapentin can cause dizziness and sleepiness, and combined with opioids it was linked to higher odds of opioid-related death.
- Misuse is uncommon in the general population but reached 15% to 22% among people who misuse opioids, and some states now monitor or control it.
It’s 2 a.m. again. You’ve tried melatonin, you’ve cut caffeine, and someone you trust mentioned that gabapentin knocked them right out. You’re tired enough to try almost anything, and you also want to know what you’d be getting into.
Gabapentin doesn’t work the way its name suggests. The Neurontin FDA label notes that gabapentin is structurally related to GABA, the brain’s main calming chemical, but has no effect on GABA binding. It binds tightly to the α2δ subunit of voltage-gated calcium channels, part of the machinery nerves use to send signals, though exactly how that produces its effects isn’t known. Matching a drug like this to a sleep problem takes precision, because its sleep effects come from a different place than most sleep aids.
The standard first step for chronic insomnia isn’t a pill. The ACP insomnia guideline strongly recommends cognitive behavioral therapy for insomnia (CBT-I), a structured program that retrains sleep habits and thoughts, as the initial treatment for all adults with chronic insomnia. Medication is reserved for when CBT-I alone hasn’t worked, after a shared discussion of benefits, harms, and costs. The results are real, and the science is well established.
But gabapentin sits outside that evidence base for most sleep problems, and at Siggy we’d rather show you exactly where the data stops than treat off-label use as a shortcut.
An evidence-matched approach asks what’s actually keeping you awake, whether gabapentin has been studied for that problem, and what the risks are for you specifically. It aims at the same goal, better sleep, without guessing. The answer depends on the cause, and the cause is clinical.
What This Page Covers
- Is Gabapentin FDA-Approved for Sleep?
- What Does the Research Show About Gabapentin and Sleep?
- When Can Gabapentin Make Sense for Sleep?
- What Are the Risks of Taking Gabapentin for Sleep?
- Can Gabapentin Be Misused?
- What Works Better for Chronic Insomnia?
- How Siggy Fits In
- Start Your Anonymous Intake
Is Gabapentin FDA-Approved for Sleep?
No. According to the label, gabapentin is approved for nerve pain that lingers after shingles (postherpetic neuralgia) in adults and as an add-on treatment for partial-onset seizures. Prescribing it for insomnia is off-label, which is legal and common in medicine but means the FDA hasn’t reviewed evidence that it works and is safe for that purpose.
Sleepiness is one reason people try it. In the label’s nerve pain trials, 21% of people on gabapentin reported sleepiness, compared with 5% on placebo. A side effect isn’t the same as a treatment, though, and what you need from a sleep medication is better sleep, not just drowsiness.
What Does the Research Show About Gabapentin and Sleep?
The most interesting finding involves slow-wave sleep, the deepest stage of sleep. In a Cleveland Clinic study, 10 healthy adults had overnight sleep studies before and after gabapentin was raised to 1,800 mg a day. Slow-wave sleep increased, and arousals and awakenings dropped slightly. It was a small study in people without insomnia.
Two larger trials tested lower doses in adults who reported occasional disturbed sleep. Both used a lab model in which people went to bed about 5 hours earlier than usual, which reliably disrupts sleep.
- In a single-dose randomized trial of 377 adults, gabapentin 250 and 500 mg cut time awake after falling asleep and increased total sleep time. Slow-wave sleep made up 12.6% of the night on placebo, 15.4% at 250 mg, and 17.0% at 500 mg. Neither dose caused measurable next-day impairment.
- In a 28-day randomized trial of 256 adults, gabapentin 250 mg reduced time awake after sleep onset and increased total sleep time on both the first and last nights, and people reported better sleep quality at home.
Those results are promising, but keep four limits in mind. Both trials were conducted with Pfizer Consumer Healthcare, whose scientists were among the authors. Participants had occasional sleep trouble, not chronic insomnia. Time to fall asleep didn’t improve in the single-dose trial, so gabapentin seemed to help people stay asleep more than fall asleep. The deep-sleep effect was also inconsistent: in the 28-day trial, the 250 mg dose didn’t significantly increase slow-wave sleep overall.
When Can Gabapentin Make Sense for Sleep?
Gabapentin’s best sleep-related evidence is for conditions that disrupt sleep, rather than insomnia on its own. The clearest example is restless legs syndrome, an urge to move the legs that worsens at night. AASM’s 2025 guideline strongly recommends gabapentin for adults with the condition, based on moderate-certainty evidence.
Here’s how the evidence lines up across common situations, based on the sources in this article.
| Situation | Evidence | Where Gabapentin Fits |
|---|---|---|
| Restless legs syndrome | Strong AASM recommendation | Recognized treatment option |
| Nerve pain after shingles | FDA-approved indication | Treats pain that may disrupt sleep |
| Occasional disrupted sleep | Two industry-linked lab-model trials | Off-label, not standard care |
| Chronic insomnia | No FDA approval, CBT-I first | Off-label, after first-line options |
If pain, restless legs, or another medical condition is behind your sleep problem, treating that condition directly often matters most. If anxiety or depression is part of what’s keeping you up, our guides to anxiety and insomnia and depression and sleep explain how treating the underlying condition can improve sleep.
What Are the Risks of Taking Gabapentin for Sleep?
Gabapentin is widely perceived as safe, but the label lists real risks:
- Dizziness and sleepiness: in the nerve pain trials, 28% had dizziness and 21% sleepiness, compared with 8% and 5% on placebo.
- Driving impairment: the label warns not to drive until you know how gabapentin affects you, and notes that people often can’t judge their own impairment well.
- Breathing problems: serious, sometimes fatal, respiratory depression has been reported when gabapentin is combined with opioids or other sedatives, or used by people with lung problems.
- Mood changes: like other antiseizure medications, gabapentin carries a warning about suicidal thoughts and behavior.
- Withdrawal: the label says to taper over at least a week, and withdrawal symptoms, including anxiety, insomnia, sweating, and nausea, have been reported after stopping.
- Kidney function: gabapentin leaves the body through the kidneys, so doses must be lowered when kidney function is reduced, which is common in older adults.
The opioid combination deserves special attention. In an Ontario population study of 1,256 opioid-related deaths and 4,619 matched controls, taking gabapentin along with an opioid was linked to 49% higher odds of opioid-related death after adjustment. Moderate and high gabapentin doses were linked to nearly 60% higher odds.
Can Gabapentin Be Misused?
Yes. A gabapentin misuse review estimated misuse at about 1% in the general population but 15% to 22% among people who misuse opioids. People described effects resembling opioids, benzodiazepines, or psychedelics, sometimes at standard doses, and misuse often involved combining gabapentin with opioids, benzodiazepines, or alcohol.
That pattern has changed how gabapentin is regulated. Gabapentin is not a controlled substance at the federal level, but a 2018 policy review found that 14 of 51 US states and jurisdictions had acted or were preparing to reclassify gabapentin or monitor its use. The rules vary by state and continue to change, so your pharmacist or state board of pharmacy is the best source for where you live.
If you have a history of substance use, tell your prescriber. It doesn’t automatically rule gabapentin out, but it changes the risk math.
What Works Better for Chronic Insomnia?
For most adults with chronic insomnia, CBT-I comes first, and the ACP guideline recommends it for everyone with the condition. It typically covers a consistent sleep schedule, limiting time in bed awake, adjusting unhelpful thoughts about sleep, and wind-down habits. Our guide to sleep hygiene for mental health covers the habit side.
When medication is considered, the choice depends on what’s keeping you up, your other conditions and medications, and your risks. Some people with depression and insomnia are prescribed low-dose sedating antidepressants, which our guide to trazodone for sleep explains. Gabapentin may make sense for some people, particularly with restless legs or nerve pain, but it works best as a deliberate choice rather than a default.
How Siggy Fits In
Long stretches of insomnia can travel with anxiety and depression, and treating only the sleep can miss what’s driving it. Months of insomnia and depressive thoughts can make life miserable, and that deserves a real plan.
Siggy’s anonymous intake needs no name, email, or account. You can describe your sleep, your mood, and every medication or substance you use, and a licensed prescriber reviews your intake before anything is prescribed. Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including insomnia, and your downloadable summary can be shared with a sleep specialist or primary care clinician if your sleep needs a separate workup.
Siggy isn’t an emergency service. This article is for education only and isn’t a substitute for personal medical advice. Don’t start, stop, or change a medication without your prescriber. It reflects sources available as of October 2026.
Start Your Anonymous Intake
If you’re in crisis right now, call 911 or call or text 988 first. If you or someone you’re with has slow or shallow breathing or can’t be woken after taking gabapentin with opioids, alcohol, or other sedatives, call 911. If sleepless nights are wearing you down, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
Is gabapentin good for sleep?
Gabapentin can deepen and lengthen sleep in some studies, but it isn't FDA-approved for insomnia. Two industry-linked trials in adults with occasional disturbed sleep found more total sleep and, at single doses, more slow-wave sleep. It has strong guideline support for restless legs syndrome. For chronic insomnia, cognitive behavioral therapy for insomnia is the recommended first treatment.
Does gabapentin increase deep sleep?
Yes, in research settings. A small study of healthy adults found more slow-wave sleep, often called deep sleep, after gabapentin was raised to 1,800 mg a day. In a larger single-dose trial, slow-wave sleep rose from 12.6% of the night on placebo to 15.4% at 250 mg and 17.0% at 500 mg.
Is gabapentin a controlled substance?
Not at the federal level in the US. Because of misuse, especially alongside opioids, a number of states have moved to reclassify gabapentin or require it to be tracked in prescription monitoring programs. The rules differ by state and change over time, so ask your pharmacist or check with your state board of pharmacy.
What are the side effects of gabapentin for sleep?
The most common side effects are sleepiness and dizziness. In the label's nerve pain trials, 21% had sleepiness and 28% had dizziness, compared with 5% and 8% on placebo. Gabapentin can impair driving, and combining it with opioids or other sedatives can slow breathing dangerously.
Can you stop gabapentin suddenly?
It's best not to. The FDA label says to taper gabapentin over at least one week when stopping or reducing it. Withdrawal symptoms such as anxiety, insomnia, sweating, and nausea have been reported after stopping, and stopping suddenly can raise seizure risk in people with epilepsy.
Sources
- U.S. Food and Drug Administration. Neurontin (gabapentin) capsules, tablets, and oral solution: prescribing information. NDA 020235. Viatris Specialty LLC. Label effective 2026. Drugs@FDA: NDA 020235
- Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. doi:10.7326/M15-2175
- Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia. 2002;43(12):1493-1497. doi:10.1046/j.1528-1157.2002.21002.x
- Rosenberg RP, Hull SG, Lankford DA, et al. A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance. J Clin Sleep Med. 2014;10(10):1093-1100. doi:10.5664/jcsm.4108
- Furey SA, Hull SG, Leibowitz MT, Jayawardena S, Roth T. A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance. J Clin Sleep Med. 2014;10(10):1101-1109. doi:10.5664/jcsm.4110
- Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025;21(1):137-152. doi:10.5664/jcsm.11390
- Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. doi:10.1371/journal.pmed.1002396
- Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160-1174. doi:10.1111/add.13324
- Peckham AM, Ananickal MJ, Sclar DA. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk Manag Healthc Policy. 2018;11:109-116. doi:10.2147/RMHP.S168504